NatalizumabReversible hyporegenerative anaemia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1544卷 / 1期

关键词：

D O I：

10.1007/s40278-015-9015-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：168 / 168

相关论文

共 50 条

[31] SirolimusHypertriglyceridaemia, hypercholesterolaemia and anaemia: 2 case reports
Reactions Weekly, 2013, 1463 (1) : 33 - 33
[32] Immune globulinHaemolytic anaemia: 2 case reports
Reactions Weekly, 2012, 1428 (1) : 21 - 21
[33] ImmunoglobulinsHaemolytic anaemia and eczema: 2 case reports
Reactions Weekly, 2009, 1236 (1) : 21 - 21
[34] MeropenemNeutropenia, nephrotoxicity and anaemia: 2 case reports
Reactions Weekly, 2014, 1513 (1) : 27 - 27
[35] FlumbatinibThrombocytopenia, leukopenia and anaemia: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 188 - 188
[36] Cefoxitin/linezolidLeucopenia and anaemia: 2 case reports
Reactions Weekly, 2020, 1786 (1) : 60 - 60
[37] CarbimazoleIron deficiency anaemia: 2 case reports
Reactions Weekly, 2012, 1390 (1) : 11 - 11
[38] Carbimazole/thiamazoleAplastic anaemia: 2 case reports
Reactions Weekly, 2008, 1232 (1) : 11 - 11
[39] ImatinibRenal dysfunction and anaemia: 2 case reports
Reactions Weekly, 2019, 1747 (1) : 147 - 147
[40] Nivolumab/pazopanibPseudoprogression and anaemia: 2 case reports
Reactions Weekly, 2019, 1749 (1) : 282 - 282

← 1 2 3 4 5 →